166 related articles for article (PubMed ID: 8689044)
1. Neural transplantation for Huntington's disease: experimental rationale and recommendations for clinical trials.
Shannon KM; Kordower JH
Cell Transplant; 1996; 5(2):339-52. PubMed ID: 8689044
[TBL] [Abstract][Full Text] [Related]
2. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease.
Pundt LL; Narang N; Kondoh T; Low WC
Neurosci Res; 1997 Apr; 27(4):305-15. PubMed ID: 9152043
[TBL] [Abstract][Full Text] [Related]
3. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease.
Peschanski M; Cesaro P; Hantraye P
Neuroscience; 1995 Sep; 68(2):273-85. PubMed ID: 7477940
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits.
Pundt LL; Kondoh T; Conrad JA; Low WC
Neurosci Res; 1996 Mar; 24(4):415-20. PubMed ID: 8861112
[TBL] [Abstract][Full Text] [Related]
5. Development of the human striatum: implications for fetal striatal transplantation in the treatment of Huntington's disease.
Freeman TB; Sanberg PR; Isacson O
Cell Transplant; 1995; 4(6):539-45. PubMed ID: 8714776
[TBL] [Abstract][Full Text] [Related]
6. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease.
Barker RA; Mason SL; Harrower TP; Swain RA; Ho AK; Sahakian BJ; Mathur R; Elneil S; Thornton S; Hurrelbrink C; Armstrong RJ; Tyers P; Smith E; Carpenter A; Piccini P; Tai YF; Brooks DJ; Pavese N; Watts C; Pickard JD; Rosser AE; Dunnett SB;
J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):657-65. PubMed ID: 23345280
[TBL] [Abstract][Full Text] [Related]
7. Progress in restorative neurosurgery: human fetal striatal transplantation in Huntington's disease. Review.
Gallina P; Paganini M; Lombardini L; Giordano G; Mascalchi M; Romoli AM; Ghelli E; Porfirio B; Vannelli GB; Di Lorenzo N
J Neurosurg Sci; 2011 Dec; 55(4):371-81. PubMed ID: 22198589
[TBL] [Abstract][Full Text] [Related]
8. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: implications for clinical trials in Huntington's disease.
Hurelbrink CB; Tyers P; Armstrong RJ; Dunnett SB; Barker RA; Rosser AE
Cell Transplant; 2003; 12(7):687-95. PubMed ID: 14653616
[TBL] [Abstract][Full Text] [Related]
9. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
Chen GJ; Jeng CH; Lin SZ; Tsai SH; Wang Y; Chiang YH
J Biomed Sci; 2002; 9(4):303-10. PubMed ID: 12145527
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of human fetal striatal tissue in Huntington's disease: rationale for clinical studies.
Freeman TB; Hauser RA; Willing AE; Zigova T; Sanberg PR; Saporta S
Novartis Found Symp; 2000; 231():129-38; discussion 139-47. PubMed ID: 11131535
[TBL] [Abstract][Full Text] [Related]
11. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
[TBL] [Abstract][Full Text] [Related]
12. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease.
Rosser AE; Barker RA; Armstrong RJ; Elneil S; Jain M; Hurelbrink CB; Prentice A; Carne C; Thornton S; Hutchinson H; Dunnett SB
Cell Transplant; 2003; 12(7):679-86. PubMed ID: 14653615
[TBL] [Abstract][Full Text] [Related]
13. Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease.
Peschanski M; Bachoud-Lévi AC; Hantraye P
Brain; 2004 Jun; 127(Pt 6):1219-28. PubMed ID: 15047588
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Tissue Preparation and Donor Age on Striatal Graft Morphology in the Mouse.
Harrison DJ; Roberton VH; Vinh NN; Brooks SP; Dunnett SB; Rosser AE
Cell Transplant; 2018 Feb; 27(2):230-244. PubMed ID: 29637815
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitter distribution in the second trimester fetal human corpus striatum.
Barami K; Hutchins KD; Lyman WD
Neurol Res; 2001 Jan; 23(1):16-22. PubMed ID: 11210425
[TBL] [Abstract][Full Text] [Related]
16. Neural transplantation of hNT neurons for Huntington's disease.
Hurlbert MS; Gianani RI; Hutt C; Freed CR; Kaddis FG
Cell Transplant; 1999; 8(1):143-51. PubMed ID: 10338282
[TBL] [Abstract][Full Text] [Related]
17. A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions.
Keene CD; Chang RC; Leverenz JB; Kopyov O; Perlman S; Hevner RF; Born DE; Bird TD; Montine TJ
Acta Neuropathol; 2009 Mar; 117(3):329-38. PubMed ID: 19057918
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of fetal neural transplants: relevance to Huntington's disease.
Sanberg PR; Koutouzis TK; Freeman TB; Cahill DW; Norman AB
Brain Res Bull; 1993; 32(5):493-6. PubMed ID: 8221141
[TBL] [Abstract][Full Text] [Related]
19. Cell therapy in Huntington's disease.
Dunnett SB; Rosser AE
NeuroRx; 2004 Oct; 1(4):394-405. PubMed ID: 15717043
[TBL] [Abstract][Full Text] [Related]
20. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
